Immunohistochemistry CD7 Test sale cost 500 AED
Maternal Serum Screen 2 Dual Test Test sale cost 500 AED Maternal Serum Screen 2 Dual Test Test Cost 560 د.إ Original price was: 560 د.إ.500 د.إCurrent price is: 500 د.إ.
Immunohistochemistry Uroplakin-III Test sale cost 500 AED Immunohistochemistry Uroplakin-III Test Cost 550 د.إ Original price was: 550 د.إ.500 د.إCurrent price is: 500 د.إ.
Sale!

Immunohistochemistry CD7 Test Cost

Original price was: 550 د.إ.Current price is: 500 د.إ.

-9%

The Immunohistochemistry CD7 Test is a specialized diagnostic procedure used to detect the presence of CD7, a protein typically found on the surface of immune cells such as T-cells and natural killer (NK) cells. This test is particularly useful in the diagnosis and classification of certain hematological disorders and lymphoid malignancies, including various types of leukemia and lymphoma. By applying specific antibodies against CD7 on tissue samples, pathologists can visually assess the expression of CD7, aiding in accurate disease identification and treatment planning.

At DNA Labs UAE, the Immunohistochemistry CD7 Test is offered for a cost of 500 AED. The lab is equipped with state-of-the-art facilities and staffed by experienced professionals to ensure high-quality, reliable results. This test is a critical tool in the arsenal of diagnostic procedures, providing essential information for the effective management of patients with suspected or confirmed hematological conditions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

IMMUNOHISTOCHEMISTRY CD7 Test Cost AED:500.0 Symptoms Diagnosis

At DNA Labs UAE, we offer the IMMUNOHISTOCHEMISTRY CD7 test at a cost of AED 500.0. This test is used to detect specific proteins in tissues using antibodies. CD7 is a cell surface glycoprotein that is expressed on T cells, natural killer (NK) cells, and a subset of hematopoietic progenitor cells. It is commonly used as a marker to identify T-cell lymphomas and leukemias.

Test Details

The CD7 test in immunohistochemistry involves several steps:

  1. Tissue preparation: Tissue samples are collected and fixed in formalin. They are then embedded in paraffin wax and sectioned into thin slices.
  2. Deparaffinization: The paraffin wax is removed from the tissue sections using xylene or other clearing agents.
  3. Antigen retrieval: The tissue sections are subjected to heat-induced antigen retrieval to unmask the CD7 antigen and enhance its accessibility to antibodies.
  4. Blocking: Non-specific binding sites on the tissue sections are blocked using a protein-based blocking reagent.
  5. Primary antibody incubation: The tissue sections are incubated with a primary antibody specific to CD7.
  6. Secondary antibody incubation: After washing off unbound primary antibody, the tissue sections are incubated with a secondary antibody conjugated to a detection system.
  7. Visualization: The detection system used in the secondary antibody can be enzymatic or fluorescent.
  8. Counterstaining: A counterstain is applied to enhance contrast and visualize tissue morphology.
  9. Examination: The tissue sections are examined under a microscope to visualize the presence and distribution of CD7-positive cells.

Pre Test Information

Before undergoing the CD7 test, please provide a copy of the Histopathology report, site of biopsy, and clinical history.

Report Delivery

The report for the CD7 test will be delivered daily by 6 pm for samples, 5 days for report blocks, 5 days for tissue biopsies, and 7 days for tissue large complexes.

Test Department

The CD7 test is conducted in the Histology department by our team of oncologists and pathologists.

Symptoms and Diagnosis

The CD7 test in immunohistochemistry helps in the diagnosis and classification of T-cell lymphomas and leukemias. It provides valuable information about the expression pattern of CD7, which can aid in determining the lineage and differentiation stage of the malignant cells.

Sample Condition

To perform the CD7 test, please submit tumor tissue in 10% Formal-saline or a Formalin-fixed paraffin-embedded block. The sample should be shipped at room temperature.

Doctor

If you have any further questions or concerns about the CD7 test, please consult with our oncologists or pathologists.

For more information, please contact DNA Labs UAE at [contact information].

Test Name IMMUNOHISTOCHEMISTRY CD7 Test
Components
Price 500.0 AED
Sample Condition Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Report Delivery Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days
Method Imunohistochemistry
Test type Cancer
Doctor Oncologist, Pathologist
Test Department: HISTOLOGY
Pre Test Information Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details

Immunohistochemistry (IHC) is a technique used to detect specific proteins in tissues using antibodies. CD7 is a cell surface glycoprotein that is expressed on T cells, natural killer (NK) cells, and a subset of hematopoietic progenitor cells. CD7 is commonly used as a marker to identify T-cell lymphomas and leukemias.

The CD7 test in immunohistochemistry involves the following steps:

1. Tissue preparation: Tissue samples are collected and fixed in formalin. They are then embedded in paraffin wax and sectioned into thin slices.

2. Deparaffinization: The paraffin wax is removed from the tissue sections using xylene or other clearing agents.

3. Antigen retrieval: The tissue sections are subjected to heat-induced antigen retrieval to unmask the CD7 antigen and enhance its accessibility to antibodies. This is typically done by heating the sections in a buffer solution.

4. Blocking: Non-specific binding sites on the tissue sections are blocked using a protein-based blocking reagent (e.g., serum or bovine serum albumin). This step helps reduce background staining.

5. Primary antibody incubation: The tissue sections are incubated with a primary antibody specific to CD7. The primary antibody binds to the CD7 antigen present on the T cells, NK cells, or hematopoietic progenitor cells.

6. Secondary antibody incubation: After washing off unbound primary antibody, the tissue sections are incubated with a secondary antibody conjugated to a detection system. The secondary antibody recognizes and binds to the primary antibody.

7. Visualization: The detection system used in the secondary antibody can be enzymatic (e.g., horseradish peroxidase) or fluorescent. Enzymatic detection systems involve the addition of a chromogenic substrate that produces a visible color change upon enzymatic reaction. Fluorescent detection systems emit light of a specific wavelength when excited by a specific light source.

8. Counterstaining: To enhance contrast and visualize tissue morphology, a counterstain (e.g., hematoxylin) is applied to the tissue sections.

9. Examination: The tissue sections are examined under a microscope to visualize the presence and distribution of CD7-positive cells. Positive staining appears as brown color (enzymatic detection) or fluorescent signal (fluorescent detection).

The CD7 test in immunohistochemistry helps in the diagnosis and classification of T-cell lymphomas and leukemias. It provides valuable information about the expression pattern of CD7, which can aid in determining the lineage and differentiation stage of the malignant cells.

SKU: TEST-6297